European Archives - Page 465 of 1369 - European Medical Journal

Tachyarrhythmia Ablation with Zero Fluoroscopy Technique in Patients Under 18 Years of Age

Ablation of cardiac arrhythmias in children under 18 years of age without the use of fluoroscopy is an effective procedure, obtaining an…

Artificial Intelligence and Digital Biomarkers: A Revolution in Cardiovascular Diagnostics

THIS YEAR, the European Society of Cardiology (ESC) Congress 2024, which took place in London, UK, between 30th August–2nd September….

ESC 2024 Abstract Highlights

The following highlights showcase groundbreaking research in cardiology, spotlighting key abstracts presented at the European Society of…

CDC Implements Marburg Virus Screening for U.S. Travelers

The CDC will screen U.S.-bound travelers from Rwanda starting October 14 due to a Marburg virus outbreak, which has resulted in 56 confirmed cases and 12 deaths

The word spotlight on a blue background

Spotlight: September 2024

Catch up on all the biggest news to hit the pharmaceutical industry this September, including new appointments, mergers and acquisitions, approvals and more.

ERS 2024 Interview: Joanna Chorostowska-Wynimko

As always, it’s about dedication and enthusiasm. My journey with the ERS began many years ago. I attended my first congress in 1994…

Rising Early-Onset Colorectal Cancer Cases Linked to Poorer Outcomes

New research has highlighted a concerning rise in early-onset colorectal cancer cases, accompanied by more aggressive disease and inferior survival.

Increased Risk of Melanoma After Radioactive Iodine Therapy for Thyroid Cancer

In patients with primary thyroid cancer, there is an increased risk of melanoma and other non-keratinocyte skin cancers after radioactive iodine therapy.

Onc Now: Episode 2: Breakthroughs in Haemato-Oncology Care

Explore the latest innovations in haemato-oncology with Aniket Mohite, a leading consultant haemato-oncologist and transplant physician in India.

Doctors in a surgery room standing in a line

Lord Darzi’s report on the NHS: What pharma needs to know

For the pharmaceutical industry, this situation highlights ways to step in as partners in healthcare innovation and support the NHS during a turbulent time.